L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 38.322 GBX -0.72%
Market Cap: 134.1m GBX
Have any thoughts about
Life Science REIT PLC?
Write Note

Wall Street
Price Targets

LABS Price Targets Summary
Life Science REIT PLC

Wall Street analysts forecast LABS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LABS is 52.02 GBX with a low forecast of 36.36 GBX and a high forecast of 63 GBX.

Lowest
Price Target
36.36 GBX
5% Downside
Average
Price Target
52.02 GBX
36% Upside
Highest
Price Target
63 GBX
64% Upside
Life Science REIT PLC Competitors:
Price Targets
SBRA
Sabra Health Care REIT Inc
18% Upside
NHI
National Health Investors Inc
24% Upside
VTR
Ventas Inc
23% Upside
CTRE
CareTrust REIT Inc
26% Upside
VHP
Vital Healthcare Property Trust
15% Upside
GMRE
Global Medical REIT Inc
41% Upside
DOC
Physicians Realty Trust
29% Upside
HC5
Healthpeak Properties Inc
28% Upside

Revenue
Forecast

Revenue Estimate
Life Science REIT PLC

For the last 1 year the compound annual growth rate for Life Science REIT PLC's revenue is 27%. The projected CAGR for the next 3 years is 7%.

27%
Past Growth
7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Life Science REIT PLC

For the last 1 year the compound annual growth rate for Life Science REIT PLC's operating income is 96%. The projected CAGR for the next 3 years is 27%.

96%
Past Growth
27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Life Science REIT PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LABS's stock price target?
Price Target
52.02 GBX

According to Wall Street analysts, the average 1-year price target for LABS is 52.02 GBX with a low forecast of 36.36 GBX and a high forecast of 63 GBX.

What is Life Science REIT PLC's Revenue forecast?
Projected CAGR
7%

For the last 1 year the compound annual growth rate for Life Science REIT PLC's revenue is 27%. The projected CAGR for the next 3 years is 7%.

What is Life Science REIT PLC's Operating Income forecast?
Projected CAGR
27%

For the last 1 year the compound annual growth rate for Life Science REIT PLC's operating income is 96%. The projected CAGR for the next 3 years is 27%.

Back to Top